Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aponermin injection for advanced chondrosarcoma (single-arm, multicenter, exploratory)
ChiCTR2500104488Phase 4Recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Jun 2025
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aponermin in chondrosarcoma, sponsored by Shanghai General Hospital. Primary endpoint: Objective response rate (ORR). Started Jun 2025; status: recruiting.
02
Drugs
aponermin
03
Conditions
chondrosarcoma
Beyond the preview
Go deeper on ChiCTR2500104488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104488.